What is ampicillin sulbactam injection used for?

Pharmaceutical Product Monograph: Ampicillin & Sulbactam Sodium Injection

In the pharmaceutical industry, the combination of Ampicillin and Sulbactam (often referred to as Sultamicillin in oral form or Co-Sultamicillin) is a broad-spectrum Beta-lactamase inhibitor antibiotic. As a pharmacist and manufacturer, I view this formulation as a “Potentiated Penicillin”—it is technically designed to extend the reach of Ampicillin to include bacteria that have evolved to produce destructive enzymes.

At your WHO-GMP facility in Mumbai, this injection is a high-volume SKU for Secondary and Tertiary Care settings. It is a cornerstone for treating mixed infections where both aerobic and anaerobic bacteria are suspected.

Therapeutic Profile: Primary Indications

Ampicillin/Sulbactam is indicated for the treatment of moderate-to-severe infections caused by susceptible strains of microorganisms.

IndicationClinical ContextTechnical Rationale
Intra-abdominal InfectionsPeritonitis / AppendicitisProvides the necessary “double coverage” for gut-related bacteria and anaerobes.
Gynecological InfectionsPID / EndometritisTreats complex pelvic inflammatory diseases often involving mixed flora.
Skin & Soft TissueDiabetic Foot / CellulitisEffective against Staphylococcus aureus and Bacteroides species in deep tissue infections.
Aspiration PneumoniaRespiratory CareThe “drug of choice” for pneumonia caused by inhaling stomach contents or mouth bacteria.
Pediatric EpiglotitisCritical ENTRapidly reduces life-threatening airway swelling caused by H. influenzae.

Mechanism: The “Suicide Inhibition” Strategy

This combination works through a dual-action biochemical process:

Ampicillin (The Bactericidal Agent): It binds to Penicillin-Binding Proteins (PBPs) in the bacterial cell wall. This prevents the “cross-linking” of the cell wall, causing the bacteria to burst (osmotic lysis).

Sulbactam (The Beta-Lactamase Inhibitor): Many bacteria produce enzymes called Beta-lactamases that destroy Ampicillin. Sulbactam is a “Suicide Inhibitor”—it binds irreversibly to these enzymes, “sacrificing” itself so that the Ampicillin remains active and effective.

Shutterstock

The Pharmacist’s “Technical Warning”

  • The “Allergy” Screen: As a pharmacist, I must emphasize that this drug is strictly contraindicated in patients with a history of Penicillin Anaphylaxis. Cross-reactivity with Cephalosporins is technically possible.

  • Renal Adjustment: Because both drugs are excreted by the kidneys, the dosage interval must be adjusted in patients with Renal Impairment ($GFR < 30 \text{ mL/min}$).

  • The “Mono” Rash: Similar to Amoxicillin, giving this to a patient with Infectious Mononucleosis (a virus) will result in a widespread, non-allergic skin rash.

  • Stability: Once reconstituted, the solution is stable for only 1 hour at room temperature (or up to 8-24 hours in a refrigerator, depending on the diluent used).

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Aseptic Filling” USP: On your digital marketplace, highlight your State-of-the-art Aseptic Powder Suite. Ampicillin/Sulbactam is highly sensitive to moisture; ensuring a 100% dry, sterile environment during filling is a technical hallmark of your WHO-GMP compliance.

  • Ratio Precision: The standard ratio is 2:1 (e.g., 1g Ampicillin to 0.5g Sulbactam). For B2B tenders, emphasize your precision in weight-uniformity, which ensures consistent therapeutic outcomes in critical care.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for 1.5g and 3g vials to support your registration in international tenders for hospital and emergency supplies.

What is amoxicillin and clavulanate potassium Injection used for?

Pharmaceutical Product Monograph: Amoxicillin & Clavulanate Potassium Injection

In the pharmaceutical industry, the combination of Amoxicillin and Clavulanate Potassium (often referred to as Co-Amoxiclav) is a broad-spectrum Beta-lactamase inhibitor antibiotic. As a pharmacist and manufacturer, I view this formulation as a “Shielded Penicillin”—it is technically designed to restore the efficacy of Amoxicillin against bacteria that have evolved to produce defensive enzymes.

At your WHO-GMP facility in Mumbai, this injection is a high-volume SKU for Secondary and Tertiary Care settings. It is the gold standard for empirical therapy when a “hidden” or mixed bacterial infection is suspected.

Therapeutic Profile: Primary Indications

Co-Amoxiclav injection is used for the short-term treatment of serious bacterial infections where oral administration is either ineffective or impossible.

IndicationClinical ContextTechnical Rationale
Severe RTIPneumonia/BronchitisTargets H. influenzae and Moraxella that produce beta-lactamase.
Surgical ProphylaxisPre-OperativeUsed in gastrointestinal, pelvic, or head and neck surgeries to prevent post-op infection.
Skin & Soft TissueCellulitis/AbscessesEffective against Staphylococci and anaerobic bacteria found in bite wounds or diabetic ulcers.
Bone & JointOsteomyelitisProvides the high tissue penetration required to treat deep-seated bone infections.
Intra-abdominalPeritonitisCovers a broad range of gut-related aerobic and anaerobic pathogens.

Mechanism: The “Shield and Sword” Strategy

This combination works through a dual-action biochemical process:

Amoxicillin (The Sword): It binds to Penicillin-Binding Proteins (PBPs) in the bacterial cell wall, inhibiting the final stage of cross-linking. This causes the cell wall to weaken and burst (osmotic lysis).

Clavulanate Potassium (The Shield): Many bacteria produce an enzyme called Beta-lactamase that “eats” the penicillin molecule before it can work. Clavulanate is a “Suicide Inhibitor”—it binds irreversibly to these enzymes, “distracting” them so the Amoxicillin can successfully attack the bacteria.

Shutterstock

The Pharmacist’s “Technical Warning”

  • The “Penicillin Allergy” Screen: As a pharmacist, I must emphasize that this drug is strictly contraindicated in anyone with a history of anaphylaxis to penicillins or cephalosporins.

  • Hepatic Monitoring: Co-Amoxiclav is technically associated with a higher risk of Cholestatic Jaundice than Amoxicillin alone. Liver function should be monitored during prolonged courses.

  • Reconstitution Stability: Once the dry powder is reconstituted with Water for Injections, it is highly unstable. It must be administered within 20 minutes; any remaining solution must be discarded.

  • Slow IV Injection: It should be administered by slow intravenous injection over 3 to 4 minutes to minimize the risk of vein irritation (thrombophlebitis).

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Moisture-Free” USP: On your digital marketplace, highlight your Aseptic Powder Filling environment. Clavulanate Potassium is extremely hygroscopic (absorbs moisture from the air). Even a trace of humidity during filling can cause the powder to turn brown and lose potency.

  • The “Twin-Pack” Offering: For international tenders, provide the vial along with a 10 mL or 20 mL Sterile Water for Injection (WFI) ampoule. This “Complete Kit” approach is a major B2B advantage for rural hospital procurement.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for strengths like 600 mg (500/100) and 1.2 g (1000/200) to support your registration in global markets.

Add to cart